About 58,300 results
Open links in new tab
  1. Lipoprotein Apheresis - Family Heart Foundation

    Lipoprotein apheresis is a nonsurgical therapy that removes high LDL cholesterol and Lp (a) from the blood. Lipoprotein apheresis is a two- to three-hour procedure where a person is connected to a …

  2. Lipid apheresis helps control chronic high cholesterol and FSGS

    Sep 22, 2023 · Unlike plasma exchange, lipid apheresis is a more specific process in which we remove only specific lipoproteins and triglycerides from the blood. Once the plasma is separated in the …

  3. Lipid Apheresis (also known as LDL apheresis) is a therapy to remove the harmful low-density lipoprotein (LDL) cholesterol that can cause serious health problems, such as cardiovascular disease.

  4. What Is Lipid Apheresis and How Does It Work?

    Jul 25, 2025 · Lipid apheresis circulates a patient’s blood outside the body, similar to kidney dialysis, to selectively remove specific lipid particles. The process separates blood components, isolates the …

  5. Lipid apheresis keeps high bad cholesterol in check - UCHealth

    May 9, 2025 · Lipid apheresis reduces average LDL cholesterol by about 40% and average Lp (a) levels by about 25%, lowering the risk of cardiovascular events such as heart attacks, strokes, or a …

  6. Advanced lipid disorders & lipoprotein apheresis - Center for ...

    For patients with certain conditions that don’t respond to daily or injectable medicines, there’s now a potentially lifesaving blood filtering intervention called LDL apheresis.

  7. Lipoprotein Apheresis - University of Kansas Medical Center

    Lipid-apheresis is therapy approved for the past 20 years by both private insurance and Medicare. Treatment is somewhat similar to the process that removes plasma from the bloodstream during a …

  8. LDL Apheresis - Cedars-Sinai

    The results of this procedure can dramatically reduce the LDL levels and help the patient avoid heart attack and stroke. The procedure takes about two to four hours and must be repeated every two to …

  9. Lipoprotein Apheresis: Utility, Outcomes, and Implementation in ...

    Oct 7, 2024 · Lipoprotein apheresis (LA) is a Food and Drug Administration (FDA) approved adjunctive therapeutic option for treating refractory high levels of low-density lipoprotein cholesterol (LDL-C) and …

  10. Lipoprotein apheresis: Current overview and future outlook in clinical ...

    Oct 1, 2025 · Lipoprotein apheresis (LA) remains a critical therapeutic approach for patients with severe lipid disorders, particularly those who fail to achieve target LDL-C or lipoprotein (a) [Lp (a)] levels …